Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
6.25
-0.16 (-2.50%)
At close: Oct 9, 2026, 4:00 PM EDT
6.25
0.00 (-0.06%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $226.83 million as of October 9, 2026. It is the 20,167th most valuable company in the world and the 3,506th biggest in the United States.
Market Cap
226.83M
Enterprise Value
34.66M
1-Year Change
n/a
Global Rank
Country Rank
#3,506 United States
Category
ChartMarket Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has decreased from $481.24M to $226.83M, a decrease of -52.87%. That is a compound annual growth rate of -55.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 226.83M | -57.97% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 241.97M |
| Q32 Bio | 240.83M |
| Pyxis Oncology | 237.72M |
| Zentalis Pharmaceuticals | 237.63M |
| Camp4 Therapeutics | 232.19M |
| Nautilus Biotechnology | 231.60M |
| Keros Therapeutics | 230.79M |
| Sol-Gel Technologies | 230.29M |